Cargando…
Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection
Clinical features of Coronavirus disease 2019 (COVID-19) are caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Acute infection management is a substantial healthcare issue, and the development of long-Covid syndrome (LCS) is extremely challenging for patients and physicians. It...
Autores principales: | Hohberger, Bettina, Harrer, Thomas, Mardin, Christian, Kruse, Friedrich, Hoffmanns, Jakob, Rogge, Lennart, Heltmann, Felix, Moritz, Michael, Szewczykowski, Charlotte, Schottenhamml, Julia, Kräter, Martin, Bergua, Antonio, Zenkel, Matthias, Gießl, Andreas, Schlötzer-Schrehardt, Ursula, Lämmer, Robert, Herrmann, Martin, Haberland, Annekathrin, Göttel, Peter, Müller, Johannes, Wallukat, Gerd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637609/ https://www.ncbi.nlm.nih.gov/pubmed/34869451 http://dx.doi.org/10.3389/fmed.2021.754667 |
Ejemplares similares
-
Long COVID: Association of Functional Autoantibodies against G-Protein-Coupled Receptors with an Impaired Retinal Microcirculation
por: Szewczykowski, Charlotte, et al.
Publicado: (2022) -
Retinal Microcirculation as a Correlate of a Systemic Capillary Impairment After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Hohberger, Bettina, et al.
Publicado: (2021) -
Post-COVID-19 Syndrome: Retinal Microcirculation as a Potential Marker for Chronic Fatigue
por: Schlick, Sarah, et al.
Publicado: (2022) -
Autoantibodies Activating the β2-Adrenergic Receptor Characterize Patients With Primary and Secondary Glaucoma
por: Hohberger, Bettina, et al.
Publicado: (2019) -
Inhibitory and Agonistic Autoantibodies Directed Against the β(2)-Adrenergic Receptor in Pseudoexfoliation Syndrome and Glaucoma
por: Hohberger, Bettina, et al.
Publicado: (2021)